HealthEquity, Inc.
HQY · Healthcare
$96.07
Caricamento grafico…
Notizie
Ultime notizie su questo titolo
Why HealthEquity Stock Sank This Week
HealthEquity stock fell 8.6% this week despite delivering sales and earnings beats in its fiscal Q2 report. The company posted adjusted EPS of $1.24 on revenue of $350.7 million, both exceeding analyst expectations. However, management's marginal increase to full-year revenue guidance and unchanged adjusted EPS guidance disappointed investors who were expecting stronger forward guidance.
HealthEquity (HQY) Q2 Earnings and Revenues Top Estimates
HealthEquity reported Q3 2026 earnings of $1.24 per share, beating consensus estimates of $1.19, with revenues of $350.73 million slightly exceeding expectations. The company has outperformed the S&P 500 by 2% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, suggesting near-term performance in line with the market.